Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports
Go Back
View Our Subscription Options

Search

Descriptive Alt Text

Filters

Showing results 1,857–1,864 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Gilead Sciences Inc. Quemliclustat, domvanalimab, zimberelimab, and chemotherapy (ARC-21) - (STAR-221) Locally advanced unresectable or metastatic gastric, gastroesophageal junction or esophageal adenocarcinoma Phase 3 Trial Discontinued Intravenous Oncology
Gilead Sciences Inc. Sacituzumab Govitecan + Pembrolizumab - (EVOKE-02) Non-Small Cell Lung Cancer (NSCLC) Phase 2 Data Released Intravenous Oncology
Glaukos Corporation PiXL Presbyopia Phase 2 Ongoing Oral Opthalmic
Glaukos Corporation GLK-301 Dry Eye Disease (DED) Phase 2a Trial Planned Intranasal Opthalmic
Glaukos Corporation iDose TR implant Intraocular pressure (IOP) Phase 2b Data Released Intracameral #N/A
Glaukos Corporation iLINK - (3rd generation) Keratoconus Phase 2 Ongoing intravitreal injection Opthalmic
GlycoMimetics Inc. Uproleselan (GMI-1271) Autologous Hematopoietic Cell Transplantation Phase 2 Intravenous Hematology
GlycoMimetics Inc. Uproleselan (GMI-1271) - NCI-sponsored Acute myeloid leukemia (AML) Phase 2/3 Data Released Intravenous Oncology
1…231232233234235…553
Your trusted source for drug reimbursement data and buy-and-bill insights.
Platform
Resources
Tools
Search Drugs
Newsletter
Reimbursement updates, drug pricing news.
© 2026 BuyandBill.com, All Rights Reserved.
HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, America's Health Insurance Plans, and Blue Cross and Blue Shield Association). CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.